The Valley Desk

ArticleLeukemiaPublished

PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Leukemia
Published
Subject terms
Cell Line, Tumor; Animals; Humans; Mice; Lymphoma, T-Cell; Cell Cycle Proteins; Proto-Oncogene Proteins; Protein Kinase Inhibitors; Xenograft Model Antitumor Assays; Apoptosis; Drug Synergism; M Phase Cell Cycle Checkpoints
PubMed ID
42443409
Added to directory
Source checked

Report a correction or request removal